Who we are
Inverness - a brief history
Founded by Ron Zwanziger in 1991, Inverness Medical Technologies (IMT) pioneered the use of 'glucose strips' for home diabetes monitoring. In 2001 the company was sold to Johnson & Johnson and Inverness Medical Innovations (IMI) was founded. With a mission to continue leading the industry in the development of innovative, consumer-focused diagnostic products, the company has grown rapidly to become a global leader in rapid diagnostics for cardiovascular disease, infectious disease, drugs of abuse, oncology and women's health.
With our focus on primary care and home testing we quickly responded to the increasing emphasis on health improvement and recently added health management companies to our portfolio. By bringing together diagnostics and health management expertise we now offer a range of 'connected' services to improve clinical outcomes and reduce costs.
The company owns numerous patented technologies and has many leading brands such as Clearview®, Cholestech LDX®, Determine® and Binax®. We employ over 11,000 people worldwide, including more than 850 in the UK. In 2009, we generated revenues of $1.9 billion, making us the sixth largest and fastest growing diagnostics company in the world.